{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:30:46Z","timestamp":1759581046320},"reference-count":58,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Differentiation"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1111\/j.1432-0436.2008.00270.x","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T19:50:56Z","timestamp":1209498656000},"page":"908-923","source":"Crossref","is-referenced-by-count":10,"title":["Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia"],"prefix":"10.1016","volume":"76","author":[{"given":"Masha","family":"Simanovsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagi","family":"Berlinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pirchia","family":"Sinai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merav","family":"Leiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Galski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1432-0436.2008.00270.x_bib1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1006\/bbrc.1999.0710","article-title":"Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues","volume":"258","author":"Adolph","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib3","doi-asserted-by":"crossref","first-page":"8912","DOI":"10.1158\/0008-5472.CAN-05-0076","article-title":"Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia","volume":"65","author":"Barnes","year":"2005","journal-title":"Cancer Res"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib2","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1038\/sj.onc.1208796","article-title":"Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemia","volume":"24","author":"Barnes","year":"2005","journal-title":"Oncogene"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI118820","article-title":"Bcr\/Abl expression stimulates integrin function in hematopoietic cell lines","volume":"98","author":"Bazzoni","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","article-title":"The chronic myelogenous leukemia-specific P210 protein is the product of the bcr\/abl hybrid gene","volume":"233","author":"Ben-Neriah","year":"1986","journal-title":"Science"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib6","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1182\/blood-2004-03-1134","article-title":"Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations","volume":"104","author":"Branford","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib7","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.V92.7.2450","article-title":"Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase","volume":"92","author":"Burgess","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib8","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/sj.onc.1204385","article-title":"Close encounters of many kinds: Fos\u2013Jun interactions that mediate transcription regulatory specificity","volume":"20","author":"Chinenov","year":"2001","journal-title":"Oncogene"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1182\/blood.V100.3.982","article-title":"Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin","volume":"100","author":"Chung","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib10","first-page":"435","article-title":"Comprehensive assessment of cell growth properties using an integrated and nonsubjective approach","volume":"2","author":"Claassen","year":"2004","journal-title":"Preclinica"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/sj.leu.2402912","article-title":"Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies","volume":"17","author":"Clarkson","year":"2003","journal-title":"Leukemia"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.hoc.2004.03.012","article-title":"Clonal evolution in chronic myelogenous leukemia","volume":"18","author":"Cortes","year":"2004","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/1097-4636(20001215)52:4<725::AID-JBM18>3.0.CO;2-O","article-title":"Integrin-mediated signaling regulates AP-1 transcription factors and proliferation in osteoblasts","volume":"52","author":"Cowles","year":"2000","journal-title":"J Biomed Mater Res"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0076-6879(94)38026-0","article-title":"Biological assays for cellular transformation","volume":"238","author":"Cox","year":"1994","journal-title":"Methods Enzymol"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/sj.leu.2402179","article-title":"Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR\/ABL inhibition, cytotoxic drugs, and gamma-irradiation","volume":"15","author":"Damiano","year":"2001","journal-title":"Leukemia"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2174\/1381612053381756","article-title":"Integrins: regulators of tissue function and cancer progression","volume":"11","author":"Danen","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/300765a0","article-title":"A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia","volume":"300","author":"DeKlein","year":"1982","journal-title":"Nature"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib17","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.leu.2404549","article-title":"Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase","volume":"21","author":"Diaz-Blanco","year":"2007","journal-title":"Leukemia"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib19","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V99.4.1388","article-title":"Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2","volume":"99","author":"Dorsey","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.1983.tb02112.x","article-title":"Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders","volume":"54","author":"Douer","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib21","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.leukres.2004.03.022","article-title":"Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia","volume":"28","author":"Drexler","year":"2004","journal-title":"Leuk Res"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.yexcr.2004.10.017","article-title":"AP-1 regulates alpha2beta1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells","volume":"304","author":"Eriksson","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9343(77)90124-3","article-title":"Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte\/macrophage","volume":"63","author":"Fialkow","year":"1977","journal-title":"Am J Med"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.leukres.2004.09.001","article-title":"Establishment and characterization of new cellular lymphoma model expressing transgenic human MDR1","volume":"294","author":"Findling-Kagan","year":"2005","journal-title":"Leuk Res"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/328342a0","article-title":"Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia","volume":"328","author":"Gordon","year":"1987","journal-title":"Nature"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib26","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/sj.leu.2400748","article-title":"BCR\/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients","volume":"11","author":"Grand","year":"1997","journal-title":"Leukemia"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.exphem.2004.02.012","article-title":"Identification of genes differentially regulated by the P210 BCR\/ABL1 fusion oncogene using cdna microarrays","volume":"32","author":"Hakansson","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng946","article-title":"Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts","volume":"32","author":"Hess","year":"2002","journal-title":"Nat Genet"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib29","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1083\/jcb.99.4.1282","article-title":"Cell adhesiveness is related to tumorigenicity in malignant lymphoid cells","volume":"99","author":"Hochman","year":"1984","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib30","first-page":"311","article-title":"Leukemia stem cells and the evolution of cancer-stem-cell research","volume":"5","author":"Huntly","year":"2005","journal-title":"Nature Rev"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00432-003-0469-z","article-title":"Quantitative reverse transcriptase polymerase chain reaction analysis for kiss-1 and orphan G-protein-coupled receptor (hot7t175) gene expression in hepatocellular carcinoma","volume":"129","author":"Ikeguchi","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib32","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/sj.leu.2401730","article-title":"Biological effects induced by variable levels of BCR-ABL protein in the pluripotent hematopoietic cell line UT-7","volume":"14","author":"Issaad","year":"2000","journal-title":"Leukemia"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib33","first-page":"1445","article-title":"Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells","volume":"56","author":"Jeha","year":"1996","journal-title":"Cancer Res"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10585-005-8186-4","article-title":"Kiss1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha","volume":"22","author":"Jiang","year":"2005","journal-title":"Clin Exp Metastasis"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib35","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.V80.7.1788.1788","article-title":"Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr\/abl","volume":"80","author":"Laneuville","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib36","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/jnci\/88.23.1731","article-title":"Kiss-1, a novel human malignant melanoma metastasis-suppressor gene","volume":"88","author":"Lee","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood.V81.1.112.112","article-title":"Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells","volume":"81","author":"Liesveld","year":"1993","journal-title":"Blood"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/CS20040336","article-title":"Chronic myeloid leukaemia: stem cell derived but progenitor cell driven","volume":"109","author":"Marley","year":"2005","journal-title":"Clin Sci (London)"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib40","doi-asserted-by":"crossref","first-page":"17126","DOI":"10.1016\/S0021-9258(17)44878-2","article-title":"Cdna sequence of the human integrin beta 5 subunit","volume":"265","author":"McLean","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib42","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1182\/blood-2006-06-032490","article-title":"Role of BCR\/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells","volume":"109","author":"Modi","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib43","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1038\/sj.onc.1206620","article-title":"Chronic myelogenous leukemia molecular signature","volume":"22","author":"Nowicki","year":"2003","journal-title":"Oncogene"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-0609.2004.00287.x","article-title":"Assessment of the response to imatinib in chronic myeloid leukemia patients\u2014comparison between the FISH, multiplex and RT-PCR methods","volume":"73","author":"Raanani","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib45","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib46","doi-asserted-by":"crossref","first-page":"11746","DOI":"10.1073\/pnas.92.25.11746","article-title":"The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation","volume":"92","author":"Raitano","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib47","first-page":"173","article-title":"BCR\/ABL-mediated increased expression of multiple known and novel genes that may contribute to the pathogenesis of chronic myelogenous leukemia","volume":"2","author":"Salesse","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib48","first-page":"256","article-title":"BCR\/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase","volume":"46","author":"Schultheis","year":"2000","journal-title":"Folia Biol (Praha)"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib49","first-page":"822","article-title":"Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics","volume":"15","author":"Seigneurin","year":"1987","journal-title":"Exp Hematol"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib50","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/sj.onc.1204383","article-title":"AP-1 in cell proliferation and survival","volume":"20","author":"Shaulian","year":"2001","journal-title":"Oncogene"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib51","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.V69.3.971.971","article-title":"Bcr-abl RNA in patients with chronic myelogenous leukemia","volume":"69","author":"Shtivelman","year":"1987","journal-title":"Blood"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib52","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1172\/JCI115985","article-title":"Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV","volume":"90","author":"Verfaillie","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib53","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1182\/blood.V99.11.4122","article-title":"BCR-ABL-induced adhesion defects are tyrosine kinase-independent","volume":"99","author":"Wertheim","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib54","doi-asserted-by":"crossref","first-page":"8612","DOI":"10.1038\/sj.onc.1206089","article-title":"The biology of chronic myelogenous leukemia: mouse models and cell adhesion","volume":"2","author":"Wertheim","year":"2002","journal-title":"Oncogene"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib55","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjc.6690765","article-title":"Suppression of the c-erbb-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells","volume":"81","author":"Wiechen","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib56","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1074\/jbc.M008681200","article-title":"Kiss-1 represses 92-kda type IV collagenase expression by down-regulating NF-\u03bab binding to the promoter as a consequence of I\u03baB\u00e1-induced block of p65\/p50 nuclear translocation","volume":"276","author":"Yan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1471-4914(02)00009-6","article-title":"Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4","volume":"9","author":"Young","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1111\/j.1432-0436.2008.00270.x_bib58","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.leu.2404227","article-title":"Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis","volume":"20","author":"Zheng","year":"2006","journal-title":"Leukemia"}],"container-title":["Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301468109600293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301468109600293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T05:22:02Z","timestamp":1631164922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301468109600293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0301468109600293"],"URL":"https:\/\/doi.org\/10.1111\/j.1432-0436.2008.00270.x","relation":{},"ISSN":["0301-4681"],"issn-type":[{"value":"0301-4681","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}